BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

被引:2601
作者
Reig, Maria [1 ,2 ]
Forner, Alejandro [1 ,2 ]
Rimola, Jordi [3 ]
Ferrer-Fabrega, Joana [4 ]
Burrel, Marta [5 ]
Garcia-Criado, Angeles [3 ]
Kelley, Robin K. [6 ]
Galle, Peter R. [7 ]
Mazzaferro, Vincenzo [8 ,9 ]
Salem, Riad [10 ]
Sangro, Bruno [2 ,11 ]
Singal, Amit G. [12 ]
Vogel, Arndt [13 ]
Fuster, Josep [2 ,4 ]
Ayuso, Carmen [2 ,3 ]
Bruix, Jordi [1 ,2 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, BCLC Grp,Liver Unit,ICMDM, Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[3] Univ Barcelona, Hosp Clin Barcelona, CDI, BCLC Grp,Radiol Dept, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, BCLC Grp,Surg Dept,ICMDM, Barcelona, Spain
[5] Univ Barcelona, BCLC Grp, Vasc Dept, CDI,Hosp Clin Barcelona,Barcelona Univ, Barcelona, Spain
[6] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Mainz Univ, Dept Internal Med, Med Ctr, Mainz, Germany
[8] Univ Milan, Dept Oncol, Milan, Italy
[9] Fdn IRCCS Ist Nazl Tumori, HPB Surg & Liver Transplantat, Milan, Italy
[10] Northwestern Univ, Dept Radiol, Sect Intervent Radiol, Chicago, IL USA
[11] Clin Univ Navarra, Liver Unit, Pamplona, Spain
[12] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
[13] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
关键词
HCC; survival; BCLC; ablation; surgery; liver transplantation TACE; TARE; systemic treatment; ALBI score; AFP; RANDOMIZED CONTROLLED-TRIAL; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; CLINICAL DECISION-MAKING; OPEN LIVER RESECTION; RADIOFREQUENCY ABLATION; TRANSARTERIAL CHEMOEMBOLIZATION; ALPHA-FETOPROTEIN; SURGICAL RESECTION; HEPATIC RESECTION; PORTAL-HYPERTENSION;
D O I
10.1016/j.jhep.2021.11.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There have been major advances in the armamentarium for hepatocellular carcinoma (HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and treatment strategy published in 2018. Whilst there have been advances in all areas, we will focus on those that have led to a change in strategy and we will discuss why, despite being encouraging, data for select interventions are still too immature for them to be incorporated into an evidence-based model for clinicians and researchers. Finally, we describe the critical insight and expert knowledge that are required to make clinical decisions for individual patients, considering all of the parameters that must be considered to deliver personalised clinical management. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:681 / 693
页数:13
相关论文
共 127 条
[51]   Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for Liver Transplantation in Patients With Hepatocellular Carcinoma Meeting the Milan Criteria [J].
Hameed, Bilal ;
Mehta, Neil ;
Sapisochin, Gonzalo ;
Roberts, John P. ;
Yao, Francis Y. .
LIVER TRANSPLANTATION, 2014, 20 (08) :945-951
[52]   Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma A PRISMA-compliant systematic review and meta-analysis [J].
Han, Jie ;
Fan, Yu-chen ;
Wang, Kai .
MEDICINE, 2020, 99 (43) :E22703
[53]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380
[54]   Methods of Public Health Research - Strengthening Causal Inference from Observational Data [J].
Hernan, Miguel A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15) :1345-1348
[55]   Liver transplantation in patients with hepatocellular carcinoma across Milan criteria [J].
Herrero, J. Ignacio ;
Sangro, Bruno ;
Pardo, Fernando ;
Quiroga, Jorge ;
Inarrairaegui, Mercedes ;
Rotellar, Fernando ;
Montiel, Custodia ;
Alegre, Felix ;
Prieto, Jesus .
LIVER TRANSPLANTATION, 2008, 14 (03) :272-278
[56]   Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival [J].
Hilgard, Philip ;
Hamami, Monia ;
El Fouly, Amr ;
Scherag, Andre ;
Mueller, Stefan ;
Ertle, Judith ;
Heusner, Till ;
Cicinnati, Vito R. ;
Paul, Andreas ;
Bockisch, Andreas ;
Gerken, Guido ;
Antoch, Gerald .
HEPATOLOGY, 2010, 52 (05) :1741-1749
[57]   Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity [J].
Ho, Won Jin ;
Zhu, Qingfeng ;
Durham, Jennifer ;
Popovic, Aleksandra ;
Xavier, Stephanie ;
Leatherman, James ;
Mohan, Aditya ;
Mo, Guanglan ;
Zhang, Shu ;
Gross, Nicole ;
Charmsaz, Soren ;
Lin, Dongxia ;
Quong, Derek ;
Wilt, Brad ;
Kamel, Ihab R. ;
Weiss, Matthew ;
Philosophe, Benjamin ;
Burkhart, Richard ;
Burns, William R. ;
Shubert, Chris ;
Ejaz, Aslam ;
He, Jin ;
Deshpande, Atul ;
Danilova, Ludmila ;
Stein-O'Brien, Genevieve ;
Sugar, Elizabeth A. ;
Laheru, Daniel A. ;
Anders, Robert A. ;
Fertig, Elana J. ;
Jaffee, Elizabeth M. ;
Yarchoan, Mark .
NATURE CANCER, 2021, 2 (09) :891-+
[58]   Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib [J].
Iavarone, Massimo ;
Cabibbo, Giuseppe ;
Biolato, Marco ;
Della Corte, Cristina ;
Maida, Marcello ;
Barbara, Marco ;
Basso, Michele ;
Vavassori, Sara ;
Craxi, Antonio ;
Grieco, Antonio ;
Camma, Carlo ;
Colombo, Massimo .
HEPATOLOGY, 2015, 62 (03) :784-791
[59]   A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial). [J].
Izumi, Namiki ;
Hasegawa, Kiyoshi ;
Nishioka, Yujiro ;
Takayama, Tadatoshi ;
Yamanaka, Naoki ;
Kudo, Masatoshi ;
Shimada, Mitsuo ;
Inomata, Masahumi ;
Kaneko, Shuichi ;
Baba, Hideo ;
Koike, Kazuhiko ;
Omata, Masao ;
Makuuchi, Masatoshi ;
Matsuyama, Yutaka ;
Kokudo, Norihiro .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[60]   Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade [J].
Johnson, Philip J. ;
Berhane, Sarah ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Teng, Mabel ;
Reeves, Helen L. ;
O'Beirne, James ;
Fox, Richard ;
Skowronska, Anna ;
Palmer, Daniel ;
Yeo, Winnie ;
Mo, Frankie ;
Lai, Paul ;
Inarrairaegui, Mercedes ;
Chan, Stephen L. ;
Sangro, Bruno ;
Miksad, Rebecca ;
Tada, Toshifumi ;
Kumada, Takashi ;
Toyoda, Hidenori .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :550-U45